SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $140,000 | -89.5% | 3,800 | -78.9% | 0.00% | -88.9% |
| Q1 2021 | $1,339,000 | -57.0% | 17,975 | -1.6% | 0.02% | -56.1% |
| Q4 2020 | $3,115,000 | +6.8% | 18,275 | -12.0% | 0.04% | 0.0% |
| Q3 2020 | $2,917,000 | -13.2% | 20,775 | -0.8% | 0.04% | -19.6% |
| Q2 2020 | $3,359,000 | +63.9% | 20,950 | 0.0% | 0.05% | +30.8% |
| Q1 2020 | $2,049,000 | -24.2% | 20,950 | 0.0% | 0.04% | -4.9% |
| Q4 2019 | $2,703,000 | +71.4% | 20,950 | 0.0% | 0.04% | +57.7% |
| Q3 2019 | $1,577,000 | – | 20,950 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |